Quick answers
- What is Anafranil?
- Anafranil is a brand name of Clomipramine hydrochloride, a prescription medicine. The FDA NDC Directory lists 3 Anafranil products in 3 strengths and forms.
- Who makes Anafranil?
- Specgx LLC holds the FDA application for Anafranil (NDA019906, approved December 29, 1989).
- Is there a generic or store brand of Anafranil?
- Yes. The FDA NDC Directory lists 48 other products with the same active ingredients, strength and form as a Anafranil product, 45 of them generic. Ask your pharmacist whether one is right for you.
- Has Anafranil been recalled?
- No recall linked to Anafranil products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Anafranil is
Each Anafranil product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Clomipramine hydrochloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| clomipramine hydrochloride 25 mg capsule (oral) | Anafranil | 16 products, 16 companies | DailyMed |
| clomipramine hydrochloride 50 mg capsule (oral) | Anafranil | 16 products, 16 companies | DailyMed |
| clomipramine hydrochloride 75 mg capsule (oral) | Anafranil | 16 products, 15 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Clomipramine hydrochloride →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA019906 | Specgx LLC | December 29, 1989 | 3 |
Companies that list Anafranil
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Anafranil products.
- SpecGx LLC3 products
Recalls
No recall linked to Anafranil products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.